Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
ClinicalTrials.gov study NCT07230691. IPD Sharing: YES. Countries: 5. Publications: 0.
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07315113. IPD Sharing: NO. Countries: 1. Publications: 0.
High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
ClinicalTrials.gov study NCT06812871. IPD Sharing: NO. Countries: 1. Publications: 0.
First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation
ClinicalTrials.gov study NCT05548348. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation
ClinicalTrials.gov study NCT03662477. IPD Sharing: YES. Countries: 1. Publications: 0.
GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial
ClinicalTrials.gov study NCT02319577. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04743505. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05498428. IPD Sharing: YES. Countries: 12. Publications: 0.
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
ClinicalTrials.gov study NCT06486142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
ClinicalTrials.gov study NCT05507606. IPD Sharing: YES. Countries: 1. Publications: 0.
Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid)
ClinicalTrials.gov study NCT02882984. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
ClinicalTrials.gov study NCT06813365. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations
ClinicalTrials.gov study NCT04695925. IPD Sharing: NO. Countries: 1. Publications: 0.
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC
ClinicalTrials.gov study NCT04768491. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
ClinicalTrials.gov study NCT06905197. IPD Sharing: NO. Countries: 2. Publications: 0.
Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment
ClinicalTrials.gov study NCT04438902. IPD Sharing: NO. Countries: 1. Publications: 0.
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
ClinicalTrials.gov study NCT03236675. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT02113813. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06706713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
ClinicalTrials.gov study NCT01717105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.